>_ QFI Terminal
TerminalStocks › DMIIR

Drugs Made In America Acquisition II Corp. Right (DMIIR) Stock

Financial Services · Asset Management · US
$0.09 +33.05%
Last updated Sep 20, 2026 14:58 UTC

DMIIR Key Statistics

Market Cap$5.92M
P/E (TTM)-32.07
P/S (TTM)
P/B (TTM)0.01
Revenue (TTM)$0.00
EPS (TTM)$0.00
Dividend Yield
ROE (TTM)-0.09%
Net Margin0.00%
Gross Margin0.00%
52W High$0.13
52W Low$0.06
Analyst View
Price Target
Employees
Volume5,955

About Drugs Made In America Acquisition II Corp. Right

Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

CEO: Roger Bendelac. Company website

DMIIR — Frequently Asked Questions

What is the DMIIR stock price today?

Drugs Made In America Acquisition II Corp. Right (DMIIR) trades at $0.09, up 33.05% on the day, as of Sep 20, 2026 14:58 UTC.

What is Drugs Made In America Acquisition II Corp. Right's market cap?

Drugs Made In America Acquisition II Corp. Right has a market capitalisation of $5.92M, calculated from the live DMIIR share price and shares outstanding.

What is the P/E ratio of DMIIR?

DMIIR has no meaningful price-to-earnings ratio: Drugs Made In America Acquisition II Corp. Right lost $0.00 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Drugs Made In America Acquisition II Corp. Right make?

Drugs Made In America Acquisition II Corp. Right generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for DMIIR?

DMIIR has traded between $0.06 and $0.13 over the past 52 weeks, and the last price is 28.5% below that high.

Is Drugs Made In America Acquisition II Corp. Right profitable?

Yes. Drugs Made In America Acquisition II Corp. Right keeps 0.00% of revenue as net income over the trailing twelve months.

What sector is Drugs Made In America Acquisition II Corp. Right in?

Drugs Made In America Acquisition II Corp. Right is classified under the Financial Services sector and the Asset Management industry, and is domiciled in US .

Who is the CEO of Drugs Made In America Acquisition II Corp. Right?

Roger Bendelac is the chief executive of Drugs Made In America Acquisition II Corp. Right.

Where can I track DMIIR in real time?

QFI Terminal shows DMIIR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See DMIIR live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open DMIIR in Terminal See plans

Asset Management stocks

BN Brookfield Corporation APO Apollo Global Management, Inc. BLK BlackRock, Inc. STT State Street Corporation KKR KKR & Co. Inc. AMP Ameriprise Financial, Inc. RJF Raymond James Financial, Inc. BX Blackstone Inc.

More Financial Services stocks

KB KB Financial Group Inc. MUFG Mitsubishi UFJ Financial Group, Inc. HDB HDFC Bank Limited IBN ICICI Bank Limited CNCK Coincheck Group N.V. BRK-B Berkshire Hathaway Inc. ITUB Itaú Unibanco Holding S.A. JPM JPMorgan Chase & Co.